What is the incidence of lung entrapment during therapeutic pleural procedures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Incidence of Lung Entrapment in Malignant Pleural Effusions

Lung entrapment (also termed nonexpandable lung or trapped lung) occurs in at least 30% of patients with malignant pleural effusions undergoing therapeutic pleural procedures 1.

Key Clinical Context

This 30% incidence represents a substantial proportion of patients and has critical implications for management decisions, particularly regarding pleurodesis candidacy. The presence of nonexpandable lung is a contraindication for pleurodesis and should redirect treatment toward indwelling pleural catheters (IPCs) as the preferred intervention 1.

Clinical Significance and Prognostic Impact

The presence of lung entrapment is not merely a technical consideration—it carries significant prognostic weight:

  • Survival impact: Patients with nonexpandable lung have markedly worse survival compared to those with expandable lung (median survival 7.5 vs. 12.7 months in one series, and 7.7 vs. 17.7 months in a Korean cohort) 1
  • Treatment implications: Attempting pleurodesis in patients with trapped lung is futile and subjects patients to unnecessary procedural risks without clinical benefit 1

Diagnostic Approach

Pre-procedure Assessment

The 2018 ATS/STS/STR guidelines recommend large-volume thoracentesis before definitive pleural intervention to identify lung entrapment 1. This serves dual purposes:

  • Confirming symptomatic improvement after fluid drainage
  • Identifying the presence of nonexpandable lung

Diagnostic Criteria

Pleural manometry during thoracentesis provides objective evidence:

  • Initial pleural fluid pressure <10 cm H₂O suggests trapped lung 2
  • Pleural elastance >13.6 cm H₂O/L is diagnostic of lung entrapment (100% sensitivity, 93% specificity) 3
  • Pressure >19 cm H₂O after removing 500 mL of fluid predicts trapped lung 2
  • Pressure >20 cm H₂O after removing 1 L of fluid is predictive of trapped lung 2

Imaging Clues

  • Absence of contralateral mediastinal shift on chest radiograph with a large effusion suggests trapped lung or endobronchial obstruction 2
  • Incomplete lung expansion after pleural space drainage warrants bronchoscopy or thoracoscopy to differentiate endobronchial obstruction from trapped lung 2

Terminology Clarification

The literature uses multiple terms interchangeably 1, 4:

  • Nonexpandable lung
  • Unexpandable lung
  • Trapped lung
  • Lung entrapment

Some authors distinguish "lung entrapment" (active malignant process causing visceral pleural peel) from "trapped lung" (fibrous peel from remote inflammation), but for clinical purposes, the 2018 ERS/EACTS statement uses "trapped lung" to encompass both entities 4.

Management Algorithm

When trapped lung is identified:

  1. Abandon pleurodesis plans - it will fail and cause unnecessary morbidity
  2. Proceed directly to IPC placement - this is the treatment of choice for nonexpandable lung 1
  3. Consider IPC with talc if expandable lung - if pleurodesis is still desired in expandable lung cases

Common pitfall: Attempting pleurodesis without first confirming lung expandability leads to treatment failure and delays appropriate palliation. Always assess lung expansion before committing to a pleurodesis strategy.

References

Guideline

management of malignant pleural effusions. an official ats/sts/str clinical practice guideline.

American Journal of Respiratory and Critical Care Medicine, 2018

Guideline

management of malignant pleural effusions.

American Journal of Respiratory and Critical Care Medicine, 2000

Research

Use of a novel ultrasound sign in the management of malignant pleural effusions: a prospective observational trial.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.